Ny Sin
- Oncology top 5%
- Peptidase Inhibition and Analysis 6
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 4
- Cancer Research top 10%
- Cell Biology top 10%
- Hematology top 10%
-
- HIV Research and Treatment 3
-
- HIV/AIDS drug development and treatment 3
-
- Carbohydrate Chemistry and Synthesis 3
-
- Respiratory viral infections research 2
- Virology and Viral Diseases 2
-
- Electron Spin Resonance Studies 2
- Co-authors
- Craig M. CrewsLihao MengBenjamin H. KwokMikael ElofssonRoyce MohanWilliam G. BornmannJames WenKyung Bo Kim
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Tetrahedron Letters (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesGermany
In The Last Decade
Ny Sin
19 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 739
- Molecular Biology 1.5k
- Cancer Research 219
- Cell Biology 206
- Hematology 119
Countries citing papers authored by Ny Sin
This map shows the geographic impact of Ny Sin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ny Sin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ny Sin more than expected).
Fields of papers citing papers by Ny Sin
This network shows the impact of papers produced by Ny Sin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ny Sin. The network helps show where Ny Sin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ny Sin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 1 | |
| 3 | 2018 | 18 | |
| 4 | 2016 | 26 | |
| 5 | 2010 | 4 | |
| 6 | 2009 | 36 | |
| 7 | 2009 | 14 | |
| 8 | 2004 | 58 | |
| 9 | 1999 | 164 | |
| 10 | 1999 | 103 | |
| 11 | Eponemycin exerts its antitumor effect through the inhibition of proteasome function. | 1999 | 132 |
| 12 | Epoxomicin, a potent and selective proteasome inhibitor, exhibitsin vivoantiinflammatory activitybreakdown → | 1999 | 803 |
| 13 | 1998 | 50 | |
| 14 | 1998 | 31 | |
| 15 | 1997 | 2 | |
| 16 | The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2breakdown → | 1997 | 530 |
| 17 | 1996 | 15 | |
| 18 | 1993 | 16 | |
| 19 | 1990 | 4 | |
| 20 | 1989 | 3 |
About Ny Sin
Ny Sin is a scholar working on Virology, Biophysics, Cancer Research, Hepatology and Organic Chemistry, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Ubiquitin and proteasome pathways (4 papers), HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers), Carbohydrate Chemistry and Synthesis (3 papers), Respiratory viral infections research (2 papers), Virology and Viral Diseases (2 papers) and Electron Spin Resonance Studies (2 papers). The work is most often cited by research in Oncology (739 citations), Molecular Biology (1.5k citations), Cancer Research (219 citations), Cell Biology (206 citations) and Hematology (119 citations). Ny Sin has collaborated with scholars based in United States and Germany. Frequent co-authors include Craig M. Crews, Lihao Meng, Benjamin H. Kwok, Mikael Elofsson, Royce Mohan, William G. Bornmann, James Wen, Kyung Bo Kim, Lin Meng and Jayhyuk Myung. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Proceedings of the National Academy of Sciences, Magnetic Resonance in Chemistry and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.